Familial hypercholesterolaemia
KEYWORDS: people, diagnosis, quality, statement, data, treatment, testing, clinical, children, specialist, hypercholesterolaemia, familial hypercholesterolaemia, clinical diagnosis, familial, source

audiences Serviceproviders ensure that systems are in place for relatives of people with a confirmed diagnosis of monogenic FH to be offered DNA testing through a nationwide, systematic cascade process. Specialists with expertise in FH offer DNA testing to relatives of people with a confirmed diagnosis of monogenic FH through a nationwide, systematic cascade process. Commissioners ensure that they commission services that offer DNA testing to relatives of people with a confirmed diagnosis of monogenic FH, through a nationwide, systematic cascade process. Relatives of people with a confirmed diagnosis of FH and a known DNA mutation are offered DNA testing themselves as part of a national scheme. Source guidance Familial hypercholesterolaemia: identification and management. NICE guideline CG71 (2008, updated 2019), recommendation 1.2.1 Definitions of terms used in this quality statement Relatives At least first- and second-degree biological relatives and third-degree biological relatives if possible. [Adapted from NICE's guideline on familial hypercholesterolaemia, terms used in this guideline] Familial hypercholesterolaemia (FH) FH relates to heterozygous FH only. Monogenic FH Present when an autosomal dominant pattern of inheritance of elevated LDL-C levels is seen in the extended family of the proband (for example, on average 50% of first-degree relatives have elevated levels). In
